Phase III, Double-Blind Study of Depot Octreotide Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy: Results of North Central Cancer Treatment Group N00CA

PURPOSE: To assess the effectiveness of depot octreotide for the prevention of diarrhea during pelvic radiation therapy. PATIENTS AND METHODS: Patients receiving pelvic radiation therapy (planned minimum dose, 45 Gy; 1.7 to 2.1 Gy daily) were eligible for the study. From May 10, 2002, through Octobe...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Martenson, James A., Halyard, Michele Y., Sloan, Jeff A., Proulx, Gary M., Miller, Robert C., Deming, Richard L., Dick, Stephen J., Johnson, Harold A., Tai, T.H. Patricia, Zhu, Angela W., Keit, Joan, Stien, Kathy J., Atherton, Pamela J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Clinical Oncology 2008
Ämnen:
Supportive Care and Quality of Life
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2652088/
https://ncbi.nlm.nih.gov/pubmed/18768432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.1546
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk